Rapid point-of-care (POC) diagnostics is a type of diagnostic test that can be performed at the point of care. It is used to diagnose diseases and other conditions, such as pregnancy, in a timely manner. Rapid POC diagnostics are typically performed by healthcare professionals in clinics, hospitals, and laboratories. The global rapid POC diagnostics market was valued at USD 3.2 billion in 2018 and is expected to reach USD 5.6 billion by 2030, growing at a CAGR of 7% from 2019 to 2030.
The global rapid POC diagnostics market has been segmented on the basis of type into instrument systems, tests software & services and applications into clinics, hospitals & laboratory respectively. The instrument systems segment accounted for the largest share of the global rapid POC diagnostics market in 2018 with an estimated value of USD 1 billion followed by tests software & services with an estimated value of USD 1 billion and applications into clinics with an estimated value of USD 0.5 billion respectively during the same year.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases is driving the demand for rapid point-of-care diagnostics.
- The increasing number of hospital acquired infections is also driving the demand for rapid point-of-care diagnostics.
- The increasing number of patients with chronic conditions such as diabetes and cancer is also driving the demand for rapid point-of-care diagnostics.
- Increasing awareness about health issues among people in developing countries is also driving the demand for rapid point-of-care diagnostics in these countries due to their low cost and ease of use compared to other diagnostic methods such as blood tests or biopsies which require trained personnel and expensive equipment to perform them properly.
- The growing need for accurate diagnosis at an early stage before a disease progresses into a more serious condition is also fueling the growth of this market.
Industry Growth Insights published a new data on “Rapid Point-of-Care (PoC) Diagnostics Market”. The research report is titled “Rapid Point-of-Care (PoC) Diagnostics Market research by Types (Instrument Systems, Tests Software & Services, ), By Applications (Clinics, Hospitals, Laboratory, Others, ), By Players/Companies Abbott, Roche, Danaher, Siemens Healthineers, BD, Quidel, Bio-Rad, BioMerieux, Abaxis, Chembio, Sekisui Diagnostics, EKF Diagnostics, Trinity Biotech, ”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Rapid Point-of-Care (PoC) Diagnostics Market Research Report
By Type
Instrument Systems, Tests Software & Services,
By Application
Clinics, Hospitals, Laboratory, Others,
By Companies
Abbott, Roche, Danaher, Siemens Healthineers, BD, Quidel, Bio-Rad, BioMerieux, Abaxis, Chembio, Sekisui Diagnostics, EKF Diagnostics, Trinity Biotech,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
 Diagnostics Industry Outlook.svg)
Global Rapid Point-of-Care (PoC) Diagnostics Market Report Segments:
The global Rapid Point-of-Care (PoC) Diagnostics market is segmented on the basis of:
Types
Instrument Systems, Tests Software & Services,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinics, Hospitals, Laboratory, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Roche
- Danaher
- Siemens Healthineers
- BD
- Quidel
- Bio-Rad
- BioMerieux
- Abaxis
- Chembio
- Sekisui Diagnostics
- EKF Diagnostics
- Trinity Biotech
 Diagnostics Market Overview.svg)
Highlights of The Rapid Point-of-Care (PoC) Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Instrument Systems
- Tests Software & Services
- By Application:
- Clinics
- Hospitals
- Laboratory
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rapid Point-of-Care (PoC) Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Diagnostics Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Rapid Point-of-Care (PoC) diagnostics is a new type of diagnostic technology that allows for the rapid detection and diagnosis of diseases or conditions in patients. PoC diagnostics use simple, easy-to-use tools that are portable and can be used by clinicians in the field.
Some of the key players operating in the rapid point-of-care (poc) diagnostics market are Abbott, Roche, Danaher, Siemens Healthineers, BD, Quidel, Bio-Rad, BioMerieux, Abaxis, Chembio, Sekisui Diagnostics, EKF Diagnostics, Trinity Biotech.
The rapid point-of-care (poc) diagnostics market is expected to register a CAGR of 7%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Rapid Point-of-Care (PoC) Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Rapid Point-of-Care (PoC) Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Rapid Point-of-Care (PoC) Diagnostics Market - Supply Chain
4.5. Global Rapid Point-of-Care (PoC) Diagnostics Market Forecast
4.5.1. Rapid Point-of-Care (PoC) Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Rapid Point-of-Care (PoC) Diagnostics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Rapid Point-of-Care (PoC) Diagnostics Market Absolute $ Opportunity
5. Global Rapid Point-of-Care (PoC) Diagnostics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Type
5.3.1. Instrument Systems
5.3.2. Tests Software & Services
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Rapid Point-of-Care (PoC) Diagnostics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Application
6.3.1. Clinics
6.3.2. Hospitals
6.3.3. Laboratory
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Rapid Point-of-Care (PoC) Diagnostics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Rapid Point-of-Care (PoC) Diagnostics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Rapid Point-of-Care (PoC) Diagnostics Demand Share Forecast, 2019-2026
9. North America Rapid Point-of-Care (PoC) Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Application
9.4.1. Clinics
9.4.2. Hospitals
9.4.3. Laboratory
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Type
9.7.1. Instrument Systems
9.7.2. Tests Software & Services
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Rapid Point-of-Care (PoC) Diagnostics Demand Share Forecast, 2019-2026
10. Latin America Rapid Point-of-Care (PoC) Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Application
10.4.1. Clinics
10.4.2. Hospitals
10.4.3. Laboratory
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Type
10.7.1. Instrument Systems
10.7.2. Tests Software & Services
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Rapid Point-of-Care (PoC) Diagnostics Demand Share Forecast, 2019-2026
11. Europe Rapid Point-of-Care (PoC) Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Application
11.4.1. Clinics
11.4.2. Hospitals
11.4.3. Laboratory
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Tye
11.7.1. Instrument Systems
11.7.2. Tests Software & Services
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Rapid Point-of-Care (PoC) Diagnostics Demand Share, 2019-2026
12. Asia Pacific Rapid Point-of-Care (PoC) Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Application
12.4.1. Clinics
12.4.2. Hospitals
12.4.3. Laboratory
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Type
12.7.1. Instrument Systems
12.7.2. Tests Software & Services
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Rapid Point-of-Care (PoC) Diagnostics Demand Share, 2019-2026
13. Middle East & Africa Rapid Point-of-Care (PoC) Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Application
13.4.1. Clinics
13.4.2. Hospitals
13.4.3. Laboratory
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Rapid Point-of-Care (PoC) Diagnostics Market Size and Volume Forecast by Type
13.7.1. Instrument Systems
13.7.2. Tests Software & Services
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Rapid Point-of-Care (PoC) Diagnostics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Rapid Point-of-Care (PoC) Diagnostics Market: Market Share Analysis
14.2. Rapid Point-of-Care (PoC) Diagnostics Distributors and Customers
14.3. Rapid Point-of-Care (PoC) Diagnostics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Roche
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Danaher
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Siemens Healthineers
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BD
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Quidel
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bio-Rad
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. BioMerieux
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Abaxis
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Chembio
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Sekisui Diagnostics
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. EKF Diagnostics
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Trinity Biotech
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14.
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
